Sugi Predict

Sugi Predict / Compounds / SCHEMBL1706804

SCHEMBL1706804

SCHEMBL1706804

COc1ccc(C(C)=O)cc1C=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ TSHR P16473 3/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA4 P22748 1/20 0.50
▸ CA6 P23280 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ TPMT P51580 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ CREBBP Q92793 1/20 0.49
▸ ERN1 O75460 4/20 0.47
▸ TLR2 O60603 1/20 0.47
▸ TLR1 Q15399 1/20 0.47
▸ TLR6 Q9Y2C9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1987664 0.87 CA12 (0.67) ALDH1A1TDP1TSHRCA12CA1
SCHEMBL29956605 0.87 CA12 (0.67) ALDH1A1TDP1TSHRCA12CA1
SCHEMBL4600083 0.87 ERN1 (0.56) ALDH1A1KMT2AMEN1TDP1KDM4E
SCHEMBL4641637 0.84 TSHR (0.50) ALDH1A1KMT2AMEN1TDP1TSHR
SCHEMBL7088677 0.84 ALDH1A1 (0.48) ALDH1A1TDP1TSHRCA12CA1
SCHEMBL310021 0.84 ERN1 (0.58) ALDH1A1KMT2AMEN1TDP1TSHR
SCHEMBL1351199 0.84 ERN1 (0.58) ALDH1A1TDP1TSHRCA12CA1
SCHEMBL31084750 0.84 ERN1 (0.58) ALDH1A1KMT2AMEN1TDP1TSHR
SCHEMBL11183546 0.83 TDP1 (0.56) ALDH1A1KMT2AMEN1TDP1TSHR
SCHEMBL4641633 0.81 CREBBP (0.40) ALDH1A1KMT2AMEN1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030124157-A1 Compositions containing aromatic aldehydes and their use in treatments ALLERGAN, INC. 2003-07-03 — — US claimed
JP-63264409-A — — None — — JP disclosed
US-12606536-B2 Bioactive phenolate ionic complexes YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2026-04-21 — — US disclosed
US-20250345269-A1 PACKAGING FOR RAPIDLY INFUSING COMPOSITION ORCOSA INC 2025-11-13 — — US disclosed
US-12383494-B2 Packaging for rapidly infusing composition ORCOSA, INC. (US) 2025-08-12 — — US disclosed
US-20250186487-A1 ORALLY SAFE BINDING SYSTEMS FOR TREATING DISEASE LIVELEAF HOLDINGS LLC (US) 2025-06-12 — — US disclosed
US-20240009129-A1 PACKAGING FOR RAPIDLY INFUSING COMPOSITION Orcosa Inc. (US) 2024-01-11 — — US disclosed
EP-4244156-A1 PACKAGING FOR RAPIDLY INFUSING COMPOSITION Orcosa Inc. (US) 2023-09-20 — — EP disclosed
US-20230234934-A1 BIOACTIVE PHENOLATE IONIC COMPLEXES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2023-07-27 — — US disclosed
US-20230106996-A1 ENHANCED ANTIVIRULENT FOR ANTIBIOTIC-RESISTANT BACTERIA LIVELEAF HOLDINGS LLC (DE) 2023-04-06 — — US disclosed
EP-2202237-A1 Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds Libragen (FR) 2010-06-30 — — EP disclosed
CN-101611148-A Water-soluble phenolic derivatives for cosmetic and therapeutic applications on the skin LIBRAGEN (FR) 2009-12-23 — — CN disclosed
WO-2008100977-A2 CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS N.V. ORGANON (NL) 2008-08-21 — — WO disclosed
US-20080004354-A1 COMPOSITIONS CONTAINING AROMATIC ALDEHYDES AND THEIR USE IN TREATMENT CUTANIX CORPORATION 2008-01-03 — — US disclosed
EP-1867729-A1 Water soluble phenolics derivatives with dermocosmetic and therapeutic applications Libragen (FR) 2007-12-19 — — EP disclosed
US-20030124157-A1 Compositions containing aromatic aldehydes and their use in treatments ALLERGAN, INC. 2003-07-03 — — US disclosed
JP-S63264409-A CARCINOSTATIC AGENT RIKAGAKU KENKYUSHO 1988-11-01 — — JP disclosed
EP-0041675-B1 4-HALOGEN-5-(TRICHLOROMETHYL-PHENYL)-OXAZOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND RADIATION-SENSITIVE COMPOSITIONS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-11 — — EP disclosed
US-4371607-A 4-Halogeno-5-(halogenomethyl-phenyl)-oxazole derivatives, a process for the preparation thereof, and radiation-sensitive compositions containing these derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-01 — — US disclosed
EP-0041675-A2 4-Halogen-5-(trichloromethyl-phenyl)-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them HOECHST AKTIENGESELLSCHAFT (DE) 1981-12-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030124157-A1 Compositions containing aromatic aldehydes and their use in treatments TYR, ALDH2, AOX1 ALDH1A1 4/4885KMT2A 2677/4885MEN1 4842/4885
US-20080004354-A1 COMPOSITIONS CONTAINING AROMATIC ALDEHYDES AND THEIR USE IN TREATMENT TYR, ALDH2, AOX1 ALDH1A1 4/4885KMT2A 2697/4885MEN1 4853/4885
US-20230234934-A1 BIOACTIVE PHENOLATE IONIC COMPLEXES PHOSPHO1, ACP3, BET1 ALDH1A1 4536/4885KMT2A 2181/4885MEN1 2945/4885
US-12606536-B2 Bioactive phenolate ionic complexes S100A6, FABP6, PTMS ALDH1A1 3616/4885KMT2A 4565/4885MEN1 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.